CAULE
León, Spain
Location contact
Manuel Fernandez Gonzalez
CONTACT
NCT Number: NCT04610021
Adult spinal deformity surgery is a complex procedure that involves many risks and complications. Bone grafts and bone substitutes are essential to achieve fusion and manage stability in spinal surgery.
Autologous bone has been considered the "gold-standard" for obtaining a spinal fusion. However, the source from which to obtain it is limited. Furthermore, the problems of bone quality in patients with osteoporosis and the morbidity have forced the orthopedic community to seek other options.
I-Factor ™ Bone Graft (Cerapedics, Inc., Westminster, CO) is a compound formed by peptide P-15 bound to an anorganic bone mineral of bovine origin that is composed of porous and smooth hydroxyapatite (ABM) particles.
In the literature there are no articles which identify bone formation with the i-Factor ™ graft in more than 4 instrumented levels, therefore the development of this study will allow assessing the fusion rate and quality of life of patients, which could lead to an improvement in the management and decision-making of surgical procedures, as well as better control of healthcare spending
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
León, Spain
Manuel Fernandez Gonzalez
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In the i-Factor ™ group it will be placed longitudinally in the intertransverse area. Likewise, in both groups, only autologous and bench bone will be placed in the intersomatic cages. The vertebrae where the i-Factor ™ is placed will be noted on the data collection sheet.
Time frame: 2 years
The success of the fusion at 12 and 24 months will be determined by a specialized radiologist by the evidence in the CT scan of trabecular bone bridges between the inter-transverse areas of the vertebral bodies and the absence of radiolucency adjacent to the implants.
Time frame: 2 years
Minimal clinically important difference is defined a smallest clinical change that is important to the patient.
Time frame: 2 years
The questions that follow ask what you think about your health. Your answers will allow you to know how you are and to what extent you are able to do your usual activities.
Patients improve when the puntuation is more than 50.
Time frame: 2 years
Disability index questionnaire
Maximun value=100 Minimun value=0
Patients improve when this index is arround 0
Time frame: 2 years
Is a measurement instrument that tries to measure a characteristic or attitude that is believed to range across a continuum of values and cannot easily be directly measured.
Maximun value=10 Minimun value=0
Patients improve when this index is arround 0
Time frame: 2 years
Scoliosis reseach society questionnaire
22 questions 5 options Dimensions Pain Function Selfimage Mental Health Satrisfaction
Puntuation for item and test: 1(worse) - 5(better)
Complejo Asistencial Universitario de León Urgencias
Other
Prospective Analysis of the i-FactorTM Bone Graft on the Fusion Rate and Quality of Life of Patients With Adult Spine Deformity
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04846296
Bone Diseases, Musculoskeletal Diseases
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07416565
Spinal Deformity
New York, United States
View Trial DetailsNCT05982808
Spinal Deformity
Hangzhou, Zhejiang, China
View Trial DetailsNCT07693465
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Giza, Egypt
View Trial Details